RE:pandoThat prediction was a few months ago.
Now I can see $5 in the future.
They just sold off their only revenue stream, and far away from any other income, with a continuing high burn rate.
Looking real bad for any investor here. Make sure that you understand the play here with management. Would you invest with a meth dealer in hopes of a return? Same scenario!!!
Best advise is to sell now at this price to avoid additional losses, unless you are short that is.
Newcamo wrote: the basher knows all that, calling a division that is making very low revenues a 'chore' business is laughable. TV got 77M$ for it....pretty nice! He is here exactly for the same reasons you are here...$$$ . Just like Plitheone that posts all the time about how horrible this is, then says he would buy at 7$.. that was a good one:)))) clowns...
pandorom999 wrote:
like realsttock said, they got 77 million $ for a uk division that was making low revenues... thomvest did excellent on this deal, and once on nasdaq, americans will be reassured on the NRs track record under lmnl ( results ) and the prospects with ripazym and pbi, this is all very short term.
realstocky wrote: it wasnt core anything, it was producing very limited revenue, and thomvest got 77 million $ for it,,,,a good deal. The future of lmnl is molecular, we have a lot in advanced stages that will be partnered next year, the real revenue producer short term is ryplazym, h1 2020... nasdaq listing this quarter will be a material event, thats why u like to post here so much...